Copy-neutral loss of heterozygosity and chromosome gains and losses are frequent in gastrointestinal stromal tumors

Molecular Cancer

Volumn 13, Issue 1, 2014, Pages

  Lourenço, Nelson ^a,h   Hélias Rodzewicz, Zofia ^a,b   Bachet, Jean Baptiste ^a,c   Brahimi Adouane, Sabrina ^a   Jardin, Fabrice ^d   Tran van Nhieu, Jeanne ^e   Peschaud, Frédérique ^a,b   Martin, Emmanuel ^f   Beauchet, Alain ^a,b   Chibon, Frédéric ^g   Emile, Jean François ^a,b  

^a LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^b HÔPITAL AMBROISE PARÉ   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d UNIVERSITÉ DE ROUEN   (France)

^e HENRI MONDOR HOSPITAL   (France)

^f IntegraGen   (France)

^g INSTITUT BERGONIÉ   (France)

^h SAINT LOUIS HOSPITAL   (France)

Author keywords

cnLOH; GIST; WT KIT allele loss

Indexed keywords

GENOMIC DNA; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2B;

ADULT; AGED; ALLELE; ARTICLE; CHROMOSOMAL INSTABILITY; CHROMOSOME 10; CHROMOSOME 11P; CHROMOSOME 11Q; CHROMOSOME 12P; CHROMOSOME 12Q; CHROMOSOME 19Q; CHROMOSOME 1P; CHROMOSOME 20P; CHROMOSOME 2Q; CHROMOSOME 3P; CHROMOSOME 4; CHROMOSOME 4Q; CHROMOSOME 9Q; CHROMOSOME ARM; CHROMOSOME DELETION; CHROMOSOME GAIN; CHROMOSOME LOSS; CHROMOSOME NUMBER; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA DETERMINATION; EXON; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GAIN OF FUNCTION MUTATION; GASTROINTESTINAL STROMAL TUMOR; GENE AMPLIFICATION; GENE DELETION; GENE MUTATION; GENETIC ASSOCIATION; HETEROZYGOSITY LOSS; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; MALE; MOLECULAR MECHANICS; NUMERICAL CHROMOSOME ABERRATION; ONCOGENE C KIT; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; SINGLE NUCLEOTIDE POLYMORPHISM; VERY ELDERLY; WILD TYPE; DISEASE COURSE; GENETICS; MIDDLE AGED; PATHOLOGY; POLYPLOIDY;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOME DELETION; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DISEASE PROGRESSION; FEMALE; GASTROINTESTINAL STROMAL TUMORS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; POLYPLOIDY;

EID: 84928642244     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-13-246     Document Type: Article

References (53)

1. Cassier PA, Ducimetière F, Lurkin A, Ranchère-Vince D, Scoazec JY, Bringuier PP, Decouvelaere AV, Méeus P, Cellier D, Blay JY, Ray-Coquard I: A prospective epidemiological study of new incident GISTs during two consecutive years in Rhône Alpes region: incidence and molecular distribution of GIST in a European region. Br J Cancer 2010, 103:165-170. 10.1038/sj.bjc.6605743
2. Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, Kawano K, Hanada M, Kurata A, Takeda M, Muhammad Tunio G, Matsuzawa Y, Kanakura Y, Shinomura Y, Kitamura Y: Gain-of-fonction mutations of c-kit in human gastrointestinal stromal tumors. Science 1998, 279:577-580. 10.1126/science.279.5350.577
3. Heinrich MC, Corless CL, Duensing A, McGreevey L, Chen CJ, Joseph N, Singer S, Griffith DJ, Haley A, Town A, Demetri GD, Fletcher CD, Fletcher JA: PDGFRA activating mutations in gastrointestinal stromal tumors. Science 2003, 299:708-710. 10.1126/science.1079666
4. Rubin BP, Heinrich MC, Corless CL: Gastrointestinal tumour. Lancet 2007, 369:1731-1741. 10.1016/S0140-6736(07)60780-6
5. Emile JF, Brahimi S, Coindre JM, Bringuier PP, Monges G, Samb P, Doucet L, Hostein I, Landi B, Buisine MP, Neuville A, Bouché O, Cervera P, Pretet JL, Tisserand J, Gauthier A, Le Cesne A, Sabourin JC, Scoazec JY, Bonvalot S, Corless CL, Heinrich MC, Blay JY, Aegerter P: Frequencies of KIT and PDGFRA mutations in the MolecGIST prospective population-based study differ from those of advanced GISTs. Med Oncol 2012, 29:1765-1772. 10.1007/s12032-011-0074-y
6. Demetri GD, von Mehren M, Blanke CD, Van den Abbeele AD, Eisenberg B, Roberts PJ, Heinrich MC, Tuveson DA, Singer S, Janicek M, Fletcher JA, Silverman SG, Silberman SL, Capdeville R, Kiese B, Peng B, Dimitrijevic S, Druker BJ, Corless C, Fletcher CD, Joensuu H: Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 2002, 347:472-480. 10.1056/NEJMoa020461
7. Dematteo RP, Ballman KV, Antonescu CR, Maki RG, Pisters PW, Demetri GD, Blackstein ME, Blanke CD, von Mehren M, Brennan MF, Patel S, McCarter MD, Polikoff JA, Tan BR, Owzar K: Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial. Lancet 2009, 373:1097-1104. 10.1016/S0140-6736(09)60500-6
8. Debiec-Rychter M, Sciot R, Le Cesne A, Schlemmer M, Hohenberger P, van Oosterom AT, Blay JY, Leyvraz S, Stul M, Casali PG, Zalcberg J, Verweij J, Van Glabbeke M, Hagemeijer A, Judson I: KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours. Eur J Cancer 2006, 42:1093-1103. 10.1016/j.ejca.2006.01.030
9. Fletcher JA: Role of KIT and Platelet-derived growth factor receptors as oncoproteins. Semin Oncol 2004, 31:4-11.
10. Corless CL, McGreevey L, Haley A, Town A, Heinrich MC: KIT mutations are common in incidental gastrointestinal stromal tumors one centimeter or less in size. Am J Pathol 2002, 160:1567-1572. 10.1016/S0002-9440(10)61103-0
11. Bachet JB, Landi B, Laurent-Puig P, Italiano A, Le Cesne A, Lévy P, Safar V, Duffaud F, Blay JY, Emile JF: Diagnosis, prognosis and treatment of patients with gastrointestinal stromal tumour (GIST) and germline mutation of KIT exon 13. Eur J Cancer 2013, 49:2531-2541. 10.1016/j.ejca.2013.04.005
12. El-Rifai W, Sarlomo-Rikala M, Miettinen M, Knuutila S, Andersson LC: DNA copy number losses in chromosome 14: an early change in gastrointestinal stromal tumors. Cancer Res 1996, 56:3230-3233.
13. Kim NG, Kim JJ, Ahn JY, Seong CM, Noh SH, Kim CB, Min JS, Kim H: Putative chromosomal deletions on 9p, 9q and22q occur preferentially in malignant gastrointestinal stromal tumors. Int J Cancer 2000, 85:633-638. 10.1002/(SICI)1097-0215(20000301)85:5<633::AID-IJC6>3.0.CO;2-5
14. El-Rifai W, Sarlomo-Rikala M, Andersson LC, Miettinen M, Knuutila S: High-resolution deletion mapping of chromosome 14 in stromal tumors of the gastrointestinal tract suggests two distinct tumor suppressor loci. Genes Chromosomes Cancer 2000, 27:387-391. 10.1002/(SICI)1098-2264(200004)27:4<387::AID-GCC8>3.0.CO;2-C
15. Breiner JA, Meis-Kindblom J, Kindblom LG, McComb E, Liu J, Nelson M, Bridge JA: Loss of 14q and 22q in gastrointestinal stromal tumors (pacemaker cell tumors). Cancer Genet Cytogenet 2000, 120:111-116. 10.1016/S0165-4608(00)00212-0
16. El-Rifai W, Sarlomo-Rikala M, Andersson LC, Knuutila S, Miettinen M: DNA sequence copy number changes in gastrointestinal stromal tumors: tumor progression and prognostic significance. Cancer Res 2000, 60:3899-3903.
17. Derré J, Lagacé R, Terrier P, Sastre X, Aurias A: Consistent DNA losses on the short arm of chromosome 1 in a series of malignant gastrointestinal stromal tumors. Cancer Genet Cytogenet 2001, 127:30-33. 10.1016/S0165-4608(00)00409-X
18. Gunawan B, von Heydebreck A, Sander B, Schulten HJ, Haller F, Langer C, Armbrust T, Bollmann M, Gasparov S, Kovac D, Fuzesi L: An oncogenetic tree model in gastrointestinal stromal tumours (GISTs) identifies different pathways of cytogenetic evolution with prognostic implications. J Pathol 2007, 211:463-470. 10.1002/path.2128
19. Chen Y, Liou CP, Tseng HH, Jan YJ, Li CF, Tzeng CC: Deletions of chromosome 1p and 15q are associated with aggressiveness of gastrointestinal stromal tumors. J Formos Med Assoc 2009, 108:28-37. 10.1016/S0929-6646(09)60029-2
20. Silva M, Veiga I, Ribeiro FR, Vieira J, Pinto C, Pinheiro M, Mesquita B, Santos C, Soares M, Dinis J, Santos L, Lopes P, Afonso M, Lopes C, Teixeira MR: Chromosome copy number changes carry prognostic information independent of KIT/PDGFRA point mutations in gastrointestinal stromal tumors. BMC Med 2010, 8:26. 10.1186/1741-7015-8-26
21. Yamamoto H, Kohashi K, Tsuneyoshi M, Oda Y: Heterozygosity loss at 22q and lack of INI1 gene mutation in gastrointestinal stromal tumor. Pathobiology 2011, 78:132-139. 10.1159/000323564
22. Théou N, Tabone S, Saffroy R, Le Cesne A, Julié C, Cortez A, Lavergne-Slove A, Debuire B, Lemoine A, Emile JF: High expression of both mutant and wild-type alleles of c-kit in gastrointestinal stromal tumors. Biochim Biophys Acta 2004, 1688:250-256. 10.1016/j.bbadis.2003.12.011
23. Emile JF, Bachet JB, Tabone-Eglinger S, Terrier P, Vignault JM: GIST with homozygous KIT exon 11 mutations. Lab Invest 2008, 88:456-457. 10.1038/labinvest.2008.13
24. Brahimi-Adouane S, Bachet JB, Tabone-Eglinger S, Subra F, Capron C, Blay JY, Emile JF: Effects of endoplasmic reticulum stressors on maturation and signaling of hemizygous and heterozygous wild-type and mutant forms of KIT. Mol Oncol 2013, 7:323-333. 10.1016/j.molonc.2012.10.008
25. Bachet JB, Tabone-Eglinger S, Dessaux S, Besse A, Brahimi-Adouane S, Emile JF, Blay JY, Alberti L: Gene expression patterns of hemizygous and heterozygous KIT mutations suggest distinct oncogenic pathways: a study in NIH3T3 cell lines and GIST samples. PLoS One 2013, 8:e61103. 10.1371/journal.pone.0061103
26. Lasota J, vel Dobosz AJ, Wasag B, Wozniak A, Kraszewska E, Michej W, Ptaszynski K, Rutkowski P, Sarlomo-Rikala M, Steigen SE, Schneider-Stock R, Stachura J, Chosia M, Ogun G, Ruka W, Siedlecki JA, Miettinen M: Presence of homozygous KIT exon 11 mutations is strongly associated with malignant clinical behaviour in gastrointestinal stromal tumors. Lab Invest 2007, 87:1029-1041. 10.1038/labinvest.3700628
27. Bergmann F, Gunawan B, Hermanns B, Höer J, Schumpelick V, Füzesi L: Cytogenetic and morphologic characteristics of gastrointestinal stromal tumors. Recurrent rearrangement of chromosome 1 and losses of chromosomes 14 and 22 as common anomalies. Verh Dtsch Ges Pathol 1998, 82:275-278.
28. Wozniak A, Sciot R, Guillou L, Pauwels P, Wasag B, Stul M, Vermeesch JR, Vandenberghe P, Limon J, Debiec-Rychter M: Array CGH analysis in primary gastrointestinal stromal tumors: cytogenetic profile correlates with anatomic site and tumor aggressiveness, irrespective of mutational status. Genes Chromosomes Cancer 2007, 46:261-276. 10.1002/gcc.20408
29. Belinsky MG, Skorobogatko YV, Rink L, Pei J, Cai KQ, Vanderveer LA, Riddell D, Merkel E, Tarn C, Eisenberg BL, von Mehren M, Testa JR, Godwin AK: High density DNA array analysis reveals distinct genomic profiles in a subset of gastrointestinal stromal tumors. Genes Chromosomes Cancer 2009, 48:886-896. 10.1002/gcc.20689
30. Lagarde P, Pérot G, Kauffmann A, Brulard C, Dapremont V, Hostein I, Neuville A, Wozniak A, Sciot R, Schöffski P, Aurias A, Coindre JM, Debiec-Rychter M, Chibon F: Mitotic checkpoints and chromosome instability are strong predictors of clinical outcome in gastrointestinal stromal tumors. Clin Cancer Res 2012, 18:826-838. 10.1158/1078-0432.CCR-11-1610
31. Engel E: A new genetic concept: uniparental disomy and its potential effect, isodisomy. Am J Med Genet 1980, 6:137-143. 10.1002/ajmg.1320060207
32. Mascari MJ, Gottlieb W, Rogan PK, Butler MG, Waller DA, Armour JA, Jeffreys AJ, Ladda RL, Nicholls RD: The frequency of uniparental disomy in Prader-Willi syndrome. Implications for molecular diagnosis. N Engl J Med 1992, 326:1599-1607. 10.1056/NEJM199206113262404
33. Murthy SK, DiFrancesco LM, Ogilvie RT, Demetrick DJ: Loss of heterozygosity associated with uniparental disomy in breast carcinoma. Mod Pathol 2002, 15:1241-1250. 10.1097/01.MP.0000032535.62750.D1
34. Raghavan M, Lillington DM, Skoulakis S, Debernardi S, Chaplin T, Foot NJ, Lister TA, Young BD: Genome-wide single nucleotide polymorphism analysis reveals frequent partial uniparental disomy due to somatic recombination in acute myeloid leukemias. Cancer Res 2005, 65:375-378.
35. Halldórsdóttir AM, Sander B, Göransson H, Isaksson A, Kimby E, Mansouri M, Rosenquist R, Ehrencrona H: High-resolution genomic screening in mantle cell lymphoma-specific changes correlate with genomic complexity, the proliferation signature and survival. Genes Chromosomes Cancer 2010, 50:113-121.
36. O'Shea D, O'Riain C, Gupta M, Waters R, Yang Y, Wrench D, Gribben J, Rosenwald A, Ott G, Rimsza LM, Holte H, Cazier JB, Johnson NA, Campo E, Chan WC, Gascoyne RD, Young BD, Staudt LM, Lister TA, Fitzgibbon J: Regions of acquired uniparental disomy at diagnosis of follicular lymphoma are associated with both overall survival and risk of transformation. Blood 2009, 113:2298-2301. 10.1182/blood-2008-08-174953
37. Chen LL, Holden JA, Choi H, Zhu J, Wu EF, Jones KA, Ward JH, Andtbacka RL, Scaife CL, Hunt KK, Prieto VG, Raymond AK, Zhang W, Trent JC, Benjamin RS, Frazier ML: Evolution from heterozygous to homozygous KIT mutation in gastrointestinal stromal tumor correlates with the mechanism of mitotic nondisjunction and significant tumor progression. Mod Pathol 2008, 21:826-836. 10.1038/modpathol.2008.46
38. Kikuchi H, Yamamoto M, Hiramatsu Y, Baba M, Ohta M, Kamiya K, Tanaka T, Suzuki S, Sugimura H, Kitagawa M, Kanai T, Kitayama Y, Kanda T, Nishikura K, Konno H: Effect of loss of heterozygosity of the c-Kit gene on prognosis after hepatectomy for metastatic liver gastrointestinal stromal tumors. Cancer Sci 2007, 98:1734-1739. 10.1111/j.1349-7006.2007.00592.x
39. Tuna M, Smid M, Martens JW, Foekens JA: Prognostic value of acquired uniparental disomy (aUPD) in primary breast cancer. Breast Cancer Res Treat 2012, 132:189-196. 10.1007/s10549-011-1579-y
40. Murayama-Hosokawa S, Oda K, Nakagawa S, Ishikawa S, Yamamoto S, Shoji K, Ikeda Y, Uehara Y, Fukayama M, McCormick F, Yano T, Taketani Y, Aburatani H: Genome-wide single-nucleotide polymorphism arrays in endometrial carcinomas associate extensive chromosomal instability with poor prognosis and unveil frequent chromosomal imbalances involved in the PI3-kinase pathway. Oncogene 2010, 23:1897-1908.
41. Darbary HK, Dutt SS, Sait SJ, Nowak NJ, Heinaman RE, Stoler DL, Anderson GR: Uniparentalism in sporadic colorectal cancer is independent of imprint status, and coordinate for chromosome 14 and 18. Cancer Genet Cytogenet 2009, 189:77-86. 10.1016/j.cancergencyto.2008.10.011
42. Van Loo P, Nordgard SH, Lingjærde OC, Russnes HG, Rye IH, Sun W, Weigman VJ, Marynen P, Zetterberg A, Naume B, Perou CM, Børresen-Dale AL, Kristensen VN: Allele-specific copy number analysis of tumors. Proc Natl Acad Sci U S A 2010, 107:16910-16915. 10.1073/pnas.1009843107
43. Makishima H, Maciejewski JP: Pathogenesis and consequences of uniparental disomy in cancer. Clin Cancer Res 2011, 17:3913-3923. 10.1158/1078-0432.CCR-10-2900
44. Raghavan M, Smith LL, Lillington DM, Chaplin T, Kakkas I, Molloy G, Chelala C, Cazier JB, Cavenagh JD, Fitzgibbon J, Lister TA, Young BD: Segmental uniparental disomy is a commonly acquired genetic event in relapsed acute myeloid leukemia. Blood 2008, 112:814-821. 10.1182/blood-2008-01-132431
45. Tuna M, Ju Z, Amos CI, Mills GB: Soft tissue sarcoma subtypes exhibit distinct patterns of acquired uniparental disomy. BMC Med Genomics 2012, 5:60. 10.1186/1755-8794-5-60
46. Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR, Tichelli A, Cazzola M, Skoda RC: A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 2005, 352:1779-1790. 10.1056/NEJMoa051113
47. Melcher R, Hartmann E, Zopf W, Herterich S, Wilke P, Müller L, Rosler E, Kudlich T, Al-Taie O, Rosenwald A, Katzenberger T, Scholtka B, Seibold S, Rogoll D, Scheppach W, Scheurlen M, Lührs H: LOH and copy neutral LOH (cnLOH) act as alternative mechanism in sporadic colorectal cancers with chromosomal and microsatellite instability. Carcinogenesis 2011, 32:636-642. 10.1093/carcin/bgr011
48. Whitman SP, Archer KJ, Feng L, Baldus C, Becknell B, Carlson BD, Carroll AJ, Mrózek K, Vardiman JW, George SL, Kolitz JE, Larson RA, Bloomfield CD, Caligiuri MA: Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia groupe B study. Cancer Res 2001, 61:7233-7739.
49. Emile JF, Lemoine A, Bienfait N, Terrier P, Azoulay D, Debuire B: Length analysis of polymerase chain reaction products: a sensitive and reliable technique for the detection of mutations in KIT exon 11 in gastrointestinal stromal tumors. Diagn Mol Pathol 2002, 11:107-112. 10.1097/00019606-200206000-00007
50. Peiffer DA, Le JM, Steemers FJ, Chang W, Jenniges T, Garcia F, Haden K, Li J, Shaw CA, Belmont J, Cheung SW, Shen RM, Barker DL, Gunderson KL: High-resolution genomic profiling of chromosomal aberrations using Infinium whole-genome genotyping. Genome Res 2006, 16:1136-1148. 10.1101/gr.5402306
51. Staaf J, Vallon-Christersson J, Lindgren D, Juliusson G, Rosenquist R, Höglund M, Borg A, Ringnér M: Normalization of Illumina Infinium whole-genome SNP data improves copy number estimates and allelic intensity ratios. BMC Bioinformatics 2008, 9:409. 10.1186/1471-2105-9-409
52. Popova T, Manié E, Stoppa-Lyonnet D, Rigaill G, Barillot E, Stern MH: Genome Alteration Print (GAP): a tool to visualize and mine complex cancer genomic profiles obtained by SNP arrays. Genome Biol 2009, 10:R128. 10.1186/gb-2009-10-11-r128
53. Jardin F, Picquenot JM, Parmentier F, Ruminy P, Cornic M, Penther D, Bertrand P, Lanic H, Cassuto O, Humbrecht C, Lemasle E, Wautier A, Bastard C, Tilly H: Detection of gene copy number aberrations in mantle cell lymphoma by a single quantitative multiplex PCR assay: clinicopathological relevance and prognosis value. Br J Haematol 2009, 146:607-618. 10.1111/j.1365-2141.2009.07791.x